Factors associated with quality of life in patients with euthyroid lymphocytic thyroiditis-a review of literature
Wiedza Medyczna · 27.08.2025 · 7 (1) · 10-16
DOI: 10.36553/wm.179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wiedza Medyczna, online erschienen am 27.08.2025. Verfasst von Aldona Janoska und 1 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben.
Abstract (Originalsprache)
Hashimoto's thyroiditis (HT) represents the most common organ-specific autoimmune disorder, characterized by chronic lymphocytic infiltration of the thyroid parenchyma and the presence of circulating antithyroid autoantibodies, predominantly thyroid peroxidase antibodies (TPO Ab) and thyroglobulin antibodies (Tg Ab). The pathogenesis of HT involves a complex interplay between genetic predisposition and environmental factors, culminating in the loss of immune tolerance and progressive destruction of thyroid tissue. Although HT remains the principal etiology of hypothyroidism in developed countries, accumulating evidence indicates that patients may exhibit systemic manifestations and reduced health-related quality of life (HRQoL) even in the euthyroid state. These clinical features are mediated by ongoing autoimmune activity, chronic inflammation, and the pathogenic effects of autoantibodies, contributing to structural and functional alterations within the thyroid gland. Furthermore, HT is frequently associated with a spectrum of comorbidities, including other autoimmune disorders, metabolic syndrome, cardiovascular diseases, psychiatric conditions, and neoplasms, which collectively exacerbate morbidity. Optimal management of HT necessitates a multidisciplinary approach that extends beyond thyroid hormone replacement to include comprehensive evaluation of psychological status and screening for concomitant diseases. This review delineates the multifactorial determinants of HRQoL impairment in HT and underscores the imperative for integrative, patient-centered therapeutic strategies. Continued research into the immunopathogenesis, novel biomarkers, and targeted interventions is essential to improve clinical outcomes and quality of life in affected individuals.
Zitieren
APA
Janoska, A., & Stelmachowska-Banaś, M. (2025). Factors associated with quality of life in patients with euthyroid lymphocytic thyroiditis-a review of literature. Wiedza Medyczna, 7(1), 10-16. https://doi.org/10.36553/wm.179
Vancouver
Janoska A, Stelmachowska-Banaś M. Factors associated with quality of life in patients with euthyroid lymphocytic thyroiditis-a review of literature. Wiedza Medyczna. 2025;7(1):10-16. doi:10.36553/wm.179
BibTeX
@article{Janoska2025,
author = {Janoska, Aldona and Stelmachowska-Banaś, Maria},
title = {Factors associated with quality of life in patients with euthyroid lymphocytic thyroiditis-a review of literature},
journal = {Wiedza Medyczna},
year = {2025},
volume = {7},
number = {1},
pages = {10--16},
doi = {10.36553/wm.179}
}
EUVIMED